There’s a new pharma bro in town...

[The beef 675] [I'm an image] “Don’t drop the soap, Martin.” - Jeff Hey there carnivores, Arguably one of the most outrageous stories of the past few months has to be Martin Shkreli aka Pharma Bro requesting release from Club Fed so he could create the cure for COVID-19 that has “so far eluded the best medical and scientific minds in the world working around the clock.” His words, not mine. Does this look like the face of the guy who could save the world? [Alternate text] Unsurprisingly, Martin’s request for early release was denied. So with Marty Biotech doing his bid upstate, it looks like the title of “Pharma Bro” is up for grabs. And I’ve got just the guy... My good friend and colleague Kyle Dennis. Why? Well, first off he is an absolute legend in the biotech trading space. PLUS he’s tracking a $2 biotech stock that he believes is going to f*cking explode. You see, it’s got a COVID med in the pipeline that is about to change the game. Wondering how you get your hands on that ticker symbol? Kyle’s only sharing it with members of his [Sniper Report](. Of course, as a member of Kyle’s Sniper Report you’ll get a whole lot more than an inside peek at just one stock. You’ll get Kyle’s real-time trade alerts via email and text message, access to his [Sniper Report live portfolio](, stock debriefings and reports and 50+ hours of video education. [So are you ready to join Kyle?]( Keep raging, [Image] Jason Bond RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 Neither Raging Bull nor RagingBull.com, LLC (publisher of Raging Bull) is registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for RagingBull.com, LLC may have long or short positions in securities that may be discussed on this website or newsletter. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are actual figures from the portfolios Raging Bull manages on behalf of RagingBull.com, LLC. If you no longer wish to receive our emails, click the link below: [Click Here to stop receiving emails from support@ragingbull.com]( [Unsubscribe from all RagingBull emails](